Toroso Investments, LLC Editas Medicine, Inc. Transaction History

Toroso Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$1.14 - $3.2 $7,102 - $19,936	-6,230 Reduced 7.61%	75,674 $87,000
Q4 2024 Feb 14, 2025	SELL	$1.2 - $3.76 $4,914 - $15,397	-4,095 Reduced 4.76%	81,904 $104,000
Q3 2024 Nov 14, 2024	SELL	$3.39 - $5.96 $106,568 - $187,358	-31,436 Reduced 26.77%	85,999 $293,000
Q2 2024 Aug 14, 2024	BUY	$4.67 - $7.28 $548,421 - $854,926	117,435 New	117,435 $548,000

227

46.2M

841K

304K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $179M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Toroso Investments, LLC with notifications on news.